ArticleMolecular therapy. Oncology2026

Engineering "off-the-shelf" TCR-T cells: A transient mRNA platform for balanced alloreactivity and functionality.

Shan He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.